|
|
|
xvii | |
| UNIT ONE Introduction to the Practice of Intravenous Therapy |
|
|
Intravenous Therapy: Past, Present, and Future Trends |
|
|
3 | (14) |
|
Renaissance Era (1438 to 1660) |
|
|
4 | (1) |
|
|
|
4 | (3) |
|
|
|
7 | (4) |
|
Advances and Trends in the 90s |
|
|
11 | (1) |
|
Trends for the 21st Century |
|
|
11 | (6) |
|
Risk Management and Quality Patient Management |
|
|
17 | (28) |
|
|
|
17 | (1) |
|
|
|
18 | (15) |
|
Quality Patient Management |
|
|
33 | (12) |
| UNIT TWO The Basics: Foundation for Practice |
|
|
Fundamentals of Fluid Balance |
|
|
45 | (28) |
|
|
|
45 | (3) |
|
|
|
48 | (1) |
|
|
|
48 | (2) |
|
|
|
50 | (3) |
|
|
|
53 | (2) |
|
|
|
55 | (4) |
|
|
|
59 | (4) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
|
|
64 | (1) |
|
|
|
64 | (9) |
|
Fundamentals of Electrolyte Balance |
|
|
73 | (42) |
|
|
|
73 | (3) |
|
Basic Principles of Electrolyte Balance |
|
|
76 | (1) |
|
Electrolytes: Function, Deficit, Excess, and Treatment |
|
|
76 | (19) |
|
|
|
95 | (1) |
|
|
|
95 | (4) |
|
|
|
99 | (1) |
|
Major Electrolyte Imbalances |
|
|
100 | (15) |
|
|
|
115 | (34) |
|
|
|
115 | (3) |
|
Rationales and Objectives of Parenteral Therapy |
|
|
118 | (5) |
|
Key Elements in Parenteral Solutions |
|
|
123 | (1) |
|
Hypotonic, Isotonic, and Hypertonic Solutions |
|
|
124 | (1) |
|
Types of Parenteral Solutions |
|
|
125 | (17) |
|
|
|
142 | (1) |
|
|
|
142 | (7) |
|
|
|
149 | (34) |
|
|
|
149 | (4) |
|
|
|
153 | (3) |
|
Basic Principles of Epidemiology |
|
|
156 | (5) |
|
Strategies for Prevention of Infection |
|
|
161 | (2) |
|
|
|
163 | (9) |
|
|
|
172 | (1) |
|
|
|
172 | (1) |
|
|
|
172 | (11) |
|
|
|
183 | (46) |
|
|
|
183 | (3) |
|
Infusion Delivery Systems |
|
|
186 | (4) |
|
|
|
190 | (5) |
|
Peripheral Infusion Devices |
|
|
195 | (9) |
|
Inline I. V. Solution Filters |
|
|
204 | (2) |
|
|
|
206 | (1) |
|
Electronic Infusion Devices (EIDs) |
|
|
207 | (8) |
|
|
|
215 | (4) |
|
|
|
219 | (1) |
|
|
|
219 | (10) |
|
Techniques for Peripheral Intravenous Therapy |
|
|
229 | (40) |
|
|
|
229 | (3) |
|
Anatomy and Physiology Related to I. V. Practice |
|
|
232 | (7) |
|
Approaches to Venipuncture |
|
|
239 | (10) |
|
Summary of Steps in Initiating I. V. Therapy |
|
|
249 | (4) |
|
Recommendations for Use of Peripheral Venous Catheters |
|
|
253 | (1) |
|
Discontinuation of I. V. Cannula |
|
|
253 | (1) |
|
Latex Resealable Lochs (PRN Devices) |
|
|
254 | (1) |
|
Heparin Flush Versus Saline Flush |
|
|
254 | (2) |
|
|
|
256 | (3) |
|
|
|
259 | (1) |
|
|
|
259 | (10) |
|
Complications of Intravenous Therapy |
|
|
269 | (44) |
|
|
|
269 | (3) |
|
|
|
272 | (19) |
|
|
|
291 | (9) |
|
|
|
300 | (2) |
|
|
|
302 | (1) |
|
|
|
302 | (11) |
|
Intravenous Therapy: Special Problems |
|
|
313 | (36) |
|
|
|
313 | (3) |
|
|
|
316 | (14) |
|
|
|
330 | (4) |
|
|
|
334 | (4) |
|
|
|
338 | (1) |
|
|
|
338 | (11) |
| UNIT THREE Advanced Practice |
|
|
Administration of Intravenous Medications |
|
|
349 | (42) |
|
|
|
349 | (4) |
|
Advantages of Intravenous Medication |
|
|
353 | (1) |
|
Disadvantages of Intravenous Medication |
|
|
353 | (4) |
|
|
|
357 | (1) |
|
Methods of Intravenous Medication Administration |
|
|
358 | (14) |
|
Anti-Infective Administration Considerations |
|
|
372 | (3) |
|
Narcotic Infusion Considerations |
|
|
375 | (3) |
|
|
|
378 | (2) |
|
|
|
380 | (1) |
|
|
|
380 | (11) |
|
Central Venous Access Devices |
|
|
391 | (48) |
|
|
|
391 | (3) |
|
Anatomy of the Vascular System |
|
|
394 | (1) |
|
Central Venous Catheter Materials |
|
|
395 | (1) |
|
Short-Term and Long-Term Access Devices |
|
|
396 | (25) |
|
Occluded Central Venous Devices |
|
|
421 | (6) |
|
|
|
427 | (1) |
|
|
|
427 | (12) |
|
|
|
439 | (52) |
|
|
|
439 | (4) |
|
|
|
443 | (5) |
|
Blood Donor Collection Methods |
|
|
448 | (3) |
|
|
|
451 | (10) |
|
|
|
461 | (1) |
|
Alternative Pharmacologic Therapies |
|
|
462 | (4) |
|
Administration of Blood Components |
|
|
466 | (8) |
|
Complications Associated with Blood Component Therapy |
|
|
474 | (6) |
|
|
|
480 | (1) |
|
|
|
480 | (11) |
|
|
|
491 | (52) |
|
|
|
491 | (4) |
|
|
|
495 | (1) |
|
|
|
496 | (3) |
|
|
|
499 | (10) |
|
Common Side Effects of Chemotherapy |
|
|
509 | (12) |
|
|
|
521 | (8) |
|
|
|
529 | (1) |
|
|
|
530 | (13) |
|
|
|
543 | (50) |
|
|
|
543 | (4) |
|
|
|
547 | (1) |
|
|
|
548 | (3) |
|
|
|
551 | (8) |
|
Modalities for Delivery of Nutritional Support |
|
|
559 | (8) |
|
Parenteral Nutrition in the Pediatric Patient |
|
|
567 | (1) |
|
Complications and Nursing Considerations |
|
|
568 | (10) |
|
Standards of Practice for Nutritional Support |
|
|
578 | (3) |
|
|
|
581 | (1) |
|
|
|
582 | (11) |
| Appendices |
|
593 | (26) |
|
Appendix A: Nomogram of Body Surface Areas |
|
|
594 | (3) |
|
Appendix B: Physical and Chemical Compatibility Chart |
|
|
597 | (5) |
|
Appendix C: Normal Laboratory Reference Values |
|
|
602 | (2) |
|
Appendix D: OSHA Guidelines 1995: Controlling Occupational Exposure to Hazardous Drugs |
|
|
604 | (8) |
|
Appendix E: Dilution of Intravenous Drugs |
|
|
612 | (4) |
|
Appendix F: Resource List of National Organizations |
|
|
616 | (1) |
|
Appendix G: Survey of Scope of Intravenous Practice by State for Licensed Practical and Vocational Nurses |
|
|
617 | (2) |
| Index |
|
619 | |